| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-303 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| filingDate |
2005-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c20e97332ce7d278cb589c3cb916a7f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d279153ea617123f26ba641a95f8ac4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d18cfa1d4c81a6c0ea101d1ce0da83fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_010cb9347e3e09eebd01cb6b47d53ded
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f2c6089efd75fe1ad2ab9f7b3d4cb8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19a3258e9fe4e0b4fd5164452553bcca |
| publicationDate |
2006-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2585196-A1 |
| titleOfInvention |
Anti-glypican 3 antibody having modified sugar chain |
| abstract |
An anti-glypican 3 antibody having a modified sugar chain, more specifically, an anti-glypican 3 antibody lacking fucose. This anti-glypican 3 antibody can be produced by a method for producing an antibody with the sugar chain modification as described above wherein a nucleic acid encoding an anti-glypican 3 antibody is transferred into host cells with lowered ability to add fucose (for example, YB2/0 cells) or fucose transporter-deficient cells and then the host cells are cultured. Because of having a high cytotoxic activity, this anti-glypican 3 antibody having a modified sugar chain is useful as a cell growth inhibitor such as an anticancer agent. |
| priorityDate |
2004-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |